Jupiter Life Line Hospitals (JLHL) Q2 26/27 earnings summary

Executive summary

• Q2FY27 consolidated revenue was ₹4,564.96 million vs ₹3,936.29 million YoY; net profit was ₹563.59 million vs ₹574.77 million.

• H1FY27 consolidated revenue was ₹8,674.79 million vs ₹7,465.82 million; net profit was ₹938.71 million vs ₹1,014.22 million.

• Capacity expansion targets growth from 1,700 to 2,900 beds; Pune South construction is on schedule, with land acquisition approved.

Financial highlights

• Q2FY27 EBITDA was ₹106.9 cr, up 15.9% YoY; PBT before exceptional items was ₹750.84 million vs ₹742.22 million.

• H1FY27 EBITDA was ₹186.2 cr, up 9.1% YoY; PBT before exceptional items was ₹1,256.37 million vs ₹1,359.70 million.

• Q2FY27 revenue from operations was ₹436.3 cr, up 15.8% YoY; total income was ₹456.5 cr, up 16.0%.

• H1FY27 revenue from operations was ₹828.8 cr, up 16.0% YoY; total income was ₹867.5 cr, up 16.2%.

Outlook and guidance

• Planned projects include Pune II (500 beds, CY28), Mira-Bhayandar (300 beds, CY29) and BKC (400 beds, CY31).

• Dombivli is being commissioned in phases: ~200 beds operational, with fit-outs completed for another 100 beds.

• Mira Road and BKC projects remain in regulatory approval and planning stages.